查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1411494

用于生物医学应用的牛胶原蛋白市场：按类型、应用和最终用户划分 - 全球预测 2024-2030

Bovine-Based Collagen for Biomedical Applications Market by Type (Type I, Type III), Application (Bone Graft Substitutes, Cartilage Repairs, Collagen-based Scaffolds), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年用于生物医学应用的牛胶原蛋白市场规模为13.7亿美元，2024年达到14.7亿美元，2030年达到26.3亿美元，复合年增长率为9.72%。

用于生物医学应用的牛胶原蛋白的全球市场

主要市场统计
基准年[2023] 13.7亿美元
预测年份 [2024] 14.7亿美元
预测年份 [2030] 26.3亿美元
复合年增长率（%） 9.72%
牛源性胶原蛋白市场-IMG1用于生物医学应用

FPNV定位矩阵

FPNV 定位矩阵对于评估生物医学应用的牛胶原蛋白市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对生物医学应用牛胶原蛋白市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-生物医学应用牛胶原蛋白市场的市场规模与预测是多少？

2-在生物医学应用牛胶原蛋白市场预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-生物医学应用牛胶原蛋白市场的技术趋势和法律规范是什么？

4-生物医学应用牛胶原蛋白市场主要供应商的市场占有率是多少？

5-进入生物医学应用牛胶原蛋白市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的高龄化，与骨骼相关的疾病的盛行率正在增加。
      • 增加对生物医药新兴企业的投资以扩大产品范围
    • 抑制因素
      • 生产流程复杂、高成本
    • 机会
      • 对牙科和整形外科的需求增加
      • 不断研发致力于创伤治疗和再生医学的发展
    • 任务
      • 疾病传播的高风险
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章生物医学应用的牛胶原蛋白市场：按类型

  • Ⅰ型
  • Ⅲ型

第七章生物医学应用的牛胶原蛋白市场：依应用分类

  • 骨移植替代物
  • 软骨修復
  • 胶原蛋白支架
  • 止血剂
  • 皮肤替代品
  • 伤口敷料

第八章生物医学应用的牛胶原蛋白市场：依最终用户分类

  • 门诊手术中心
  • 医院

第九章美洲生物医学应用牛胶原蛋白市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区牛胶原蛋白生物医学应用市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲生物医学应用牛胶原蛋白市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Advanced BioMatrix Inc.
    • BBI Solutions
    • Botiss biomaterials GmbH
    • Bovine Collagen Products
    • Collagen Matrix, Inc.
    • Collagen Solutions PLC
    • Crescent Biotech
    • Darling Ingredients
    • Eucare Pharmaceuticals Private Limited
    • Fisher Scientific International, Inc.
    • Gelita AG
    • Getinge AB
    • Integra LifeSciences Holdings Corporation
    • InterHealth Nutraceuticals Inc.
    • Lapi Gelatine SpA
    • Medtronic PLC
    • Nippi,incorporated
    • Nitta Gelatin, Inc.
    • NuCollagen LLC
    • Shenzhen Ruifuer Electronic Co., Ltd.
    • Symatese
    • Tessenderlo Group
    • Titan Biotech Ltd.
    • Viscofan DE GmbH
    • Weishardt International
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-5C6F41F5B051

[193 Pages Report] The Bovine-Based Collagen for Biomedical Applications Market size was estimated at USD 1.37 billion in 2023 and expected to reach USD 1.47 billion in 2024, at a CAGR 9.72% to reach USD 2.63 billion by 2030.

Global Bovine-Based Collagen for Biomedical Applications Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.37 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 2.63 billion
CAGR (%) 9.72%
Bovine-Based Collagen for Biomedical Applications Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bovine-Based Collagen for Biomedical Applications Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bovine-Based Collagen for Biomedical Applications Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bovine-Based Collagen for Biomedical Applications Market, highlighting leading vendors and their innovative profiles. These include Advanced BioMatrix Inc., BBI Solutions, Botiss biomaterials GmbH, Bovine Collagen Products, Collagen Matrix, Inc., Collagen Solutions PLC, Crescent Biotech, Darling Ingredients, Eucare Pharmaceuticals Private Limited, Fisher Scientific International, Inc., Gelita AG, Getinge AB, Integra LifeSciences Holdings Corporation, InterHealth Nutraceuticals Inc., Lapi Gelatine S.p.A., Medtronic PLC, Nippi,incorporated, Nitta Gelatin, Inc., NuCollagen LLC, Shenzhen Ruifuer Electronic Co., Ltd., Symatese, Tessenderlo Group, Titan Biotech Ltd., Viscofan DE GmbH, and Weishardt International.

Market Segmentation & Coverage

This research report categorizes the Bovine-Based Collagen for Biomedical Applications Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Type I
    • Type III
  • Application
    • Bone Graft Substitutes
    • Cartilage Repairs
    • Collagen-based Scaffolds
    • Hemostats
    • Skin Substitutes
    • Wound Dressing
  • End-user
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Bovine-Based Collagen for Biomedical Applications Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bovine-Based Collagen for Biomedical Applications Market?

3. What are the technology trends and regulatory frameworks in the Bovine-Based Collagen for Biomedical Applications Market?

4. What is the market share of the leading vendors in the Bovine-Based Collagen for Biomedical Applications Market?

5. Which modes and strategic moves are suitable for entering the Bovine-Based Collagen for Biomedical Applications Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Bovine-Based Collagen for Biomedical Applications Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging of populations worldwide and increasing prevalence of bone-related diseases
      • 5.1.1.2. Rising investments in biomedical startups to expand their offerings
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with complex and intricate production processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for dental and orthopedic surgeries
      • 5.1.3.2. Ongoing R&D for the development of wound healing and regenerative medicines
    • 5.1.4. Challenges
      • 5.1.4.1. High risk of transmission of diseases
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Bovine-Based Collagen for Biomedical Applications Market, by Type

  • 6.1. Introduction
  • 6.2. Type I
  • 6.3. Type III

7. Bovine-Based Collagen for Biomedical Applications Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Graft Substitutes
  • 7.3. Cartilage Repairs
  • 7.4. Collagen-based Scaffolds
  • 7.5. Hemostats
  • 7.6. Skin Substitutes
  • 7.7. Wound Dressing

8. Bovine-Based Collagen for Biomedical Applications Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Bovine-Based Collagen for Biomedical Applications Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bovine-Based Collagen for Biomedical Applications Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bovine-Based Collagen for Biomedical Applications Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Advanced BioMatrix Inc.
    • 13.1.2. BBI Solutions
    • 13.1.3. Botiss biomaterials GmbH
    • 13.1.4. Bovine Collagen Products
    • 13.1.5. Collagen Matrix, Inc.
    • 13.1.6. Collagen Solutions PLC
    • 13.1.7. Crescent Biotech
    • 13.1.8. Darling Ingredients
    • 13.1.9. Eucare Pharmaceuticals Private Limited
    • 13.1.10. Fisher Scientific International, Inc.
    • 13.1.11. Gelita AG
    • 13.1.12. Getinge AB
    • 13.1.13. Integra LifeSciences Holdings Corporation
    • 13.1.14. InterHealth Nutraceuticals Inc.
    • 13.1.15. Lapi Gelatine S.p.A.
    • 13.1.16. Medtronic PLC
    • 13.1.17. Nippi,incorporated
    • 13.1.18. Nitta Gelatin, Inc.
    • 13.1.19. NuCollagen LLC
    • 13.1.20. Shenzhen Ruifuer Electronic Co., Ltd.
    • 13.1.21. Symatese
    • 13.1.22. Tessenderlo Group
    • 13.1.23. Titan Biotech Ltd.
    • 13.1.24. Viscofan DE GmbH
    • 13.1.25. Weishardt International
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET RESEARCH PROCESS
  • FIGURE 2. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET DYNAMICS
  • FIGURE 7. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY CARTILAGE REPAIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COLLAGEN-BASED SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY SKIN SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY WOUND DRESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 146. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. BOVINE-BASED COLLAGEN FOR BIOMEDICAL APPLICATIONS MARKET LICENSE & PRICING